RARE Partnering and Investor Forum

 

THE FIRST-EVER RARE DISEASE PARTNERING EVENT
WHERE SCIENCE INNOVATORS AND INVESTORS CONVERGE

September 14, 2017
Irvine Hotel, Irvine, CA

 

 
Early Bird Registration Pricing Ends July 31st

EBD Group’s 1:1 Partnering Platform
Compelling Agenda with Industry Experts * Company Presentations
‘Shark Tank’-Style Pitch Competition Featuring Promising Early Stage Companies
Vying for Valuable Goods and Services

 

Participating Partners and Investors (to date):

John Crowley, Chairman and CEO, Amicus Therapeutics Brad Margus, Founder & CEO, Cerevance
Bharatt Chowrira, President & Chief of Business & Strategy, PureTech Health Camille Samuels, Managing Partner, Venrock
Neil Kumar, CEO, BridgeBio Alison Silva, CEO & President, Critical Outcome Technologies Inc., The Orphan Group
Michael Pistone, Strategic Marketing & Business Development, Cincinnati Children’s Hospital Matthew Howes, EVP, Strategy & Growth, Palio
Jeremy Springhorn, Flagship Pioneering Ashish Sagrolikare, Office of Commercial Transformation, GSK
Art Pappas, Managing Partner, Pappas Capital Vern Norviel, Partner, Wilson Sonsini Goodrich & Rosati
Kush Parmar, MD, Ph.D., Managing Partner,
5AM Ventures
Michael Broxson, VP, Manager Business Development, Takeda Pharmaceuticals

 

 

        2014 Patient Summit & Corp Alliance        
    

 

Innovators and Investors will converge at RARE Partnering, an event not to be miss​ed. #2017GGForum 

 

Sponsors:

 

 

 

 

 

      ebd-square           

         

    

In Partnership with:

ARM_Logo-bright-cmyk2            Print      

           

 

 
For more information on partnering, email Nicoleb@globalgenes.org.